The COBRE Center for Neurodegeneration and Translational Neuroscience (CNTN) is proposed by a coalition of Cleveland Clinic Lou Ruvo Center for Brain Health (LRCBH) in Las Vegas, NV and the University of Nevada Las Vegas (UNLV) to: 1) establish an independent and sustainable infrastructure for translational research that will create a rich and unique scientific environment; 2) provide a transformative research training experience for 3 junior investigators/Project Leaders working in the area of neurodegenerative disorders (NDD); and 3) advance understanding of Alzheimer's disease (AD) and Parkinson's disease (PD), the two most common NDD. The CNTN will consist of 3 cores and 3 projects plus internal and external advisory committees. The Administrative Core will lead the vision, administrative oversight, budgetary and reporting aspects of the center, and will support the formative and summative assessment processes. The Data Management and Statistics Core will provide the technical hardware and software for data management for all aspects of the CNTN as well as providing expert statistical input on project design, analysis and interpretation. The Clinical and Translational Research Core will establish a well-characterized cohort of healthy controls (HC) and patients with AD or PD for Projects 1 and 2 as well as other junior investigators attracted to the CNTN. Project 1 will investigate the resting state default mode network with functional Magnetic Resonance Imaging (fMRI) in patients with mild cognitive impairment (MCI), mild-moderate AD, and HC. Project 1 will also use a novel positron emission tomography ligand to investigate microglial activity in AD, PD, and HC. Project 2 will use fMRI and diffusion tensor imaging to study the biological underpinnings of cognitive impairment in PD. Project 3 investigates the role of GABA receptors in the control of microglial activity in animal models of AD. A multifaceted mentoring program provides both local scientific mentors and specialist scientific mentors to all junior investigators. COBRE funds complemented by institutional commitment from LRCBH will be used to hire an imaging expert who will serve as mentor for Projects 1 and 2 as well as strengthening the research environment.

Public Health Relevance

The proposed Center for Neurodegeneration and Translational Neuroscience will capitalize on the resources of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, NV and the University of Nevada Las Vegas to develop a sustainable research center that will advance the careers of junior investigators and increase our understanding of Alzheimer's disease and Parkinson's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
1P20GM109025-01A1
Application #
8812114
Study Section
Special Emphasis Panel (ZGM1-TWD-0)
Program Officer
Gorospe, Rafael
Project Start
2015-09-01
Project End
2020-05-31
Budget Start
2015-09-01
Budget End
2016-05-31
Support Year
1
Fiscal Year
2015
Total Cost
$2,167,171
Indirect Cost
$517,650
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Cummings, Jeffrey; Scheltens, Philip; McKeith, Ian et al. (2017) Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease. J Alzheimers Dis 55:1131-1139
Cummings, J; Fox, N (2017) Defining Disease Modifying Therapy for Alzheimer's Disease. J Prev Alzheimers Dis 4:109-115
Ritter, Aaron; Hawley, Nanako; Banks, Sarah J et al. (2017) The Association between Montreal Cognitive Assessment Memory Scores and Hippocampal Volume in a Neurodegenerative Disease Sample. J Alzheimers Dis 58:695-699
Sreenivasan, Karthik; Zhuang, Xiaowei; Banks, Sarah J et al. (2017) Olfactory Network Differences in Master Sommeliers: Connectivity Analysis Using Granger Causality and Graph Theoretical Approach. Brain Connect 7:123-136
Ghazi-Saidi, Ladan; Walsh, Ryan R; Shan, Guogen et al. (2017) Biomarkers of Cognitive Impairment: Brain Cortical Thickness, Volumetrics, and Cerebrospinal Fluid. Alzheimer Dis Assoc Disord :
Mishra, Virendra R; Zhuang, Xiaowei; Sreenivasan, Karthik R et al. (2017) Multimodal MR Imaging Signatures of Cognitive Impairment in Active Professional Fighters. Radiology 285:555-567
Bloniecki, Victor; Aarsland, Dag; Blennow, Kaj et al. (2017) Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid. J Alzheimers Dis 57:387-393
Zhuang, Xiaowei; Yang, Zhengshi; Curran, Tim et al. (2017) A family of locally constrained CCA models for detecting activation patterns in fMRI. Neuroimage 149:63-84
Zhang, Hua; Jiang, Tao; Shan, Guogen et al. (2017) Gaussian network model can be enhanced by combining solvent accessibility in proteins. Sci Rep 7:7486
Yang, Zhengshi; Zhuang, Xiaowei; Sreenivasan, Karthik et al. (2017) 3D spatially-adaptive canonical correlation analysis: Local and global methods. Neuroimage 169:240-255

Showing the most recent 10 out of 26 publications